Greyledge Adapts Cutting Edge Computer Technology to Enhance Cell Therapy Products

The field of Regenerative Medicine is evolving and each day studies are published leading to advancements in the way physicians treat patients. Greyledge believes that collecting and carefully analyzing product and patient data that helps physicians improve patient outcomes is vital to the ongoing success of the field. Using our analytical models, we can compare [...]

Stem cell treatments and PRP (Platelet Rich Plasma) therapy are both treatment options in the regenerative medicine field, which continues to grow rapidly. As more patients see promising results from the use of these biologic treatments, more new patients are opting for biologic solutions every day. But many patients who are interested in employing biologics [...]

There are three main themes that I have discussed so far that have stood out during my review of the two-day Workshop the FDA held on September 12 and 13. These themes are: Corporate needs should dictate the interpretation and application of the law that governs the use of patient-derived materials (including dead peoples’ parts [...]

Part One of my review of the speakers’ comments at the two-day stakeholder workshop the FDA held on September 12 and 13 to review four draft Guidances the Agency wants to finalize can be found here(opens in a new tab). The theme I had started with was the irony associated with certain speakers of large corporations [...]

While I was settling in at my new job with Greyledge Technologies in Colorado, the FDA held a two-day stakeholder meeting to review four draft guidances the Agency wants to finalize. The four draft guidances are (in the order they were issued): Same Surgical Procedure Exception (October, 2014; source(opens in a new tab)) Minimal Manipulation (December, 2014; source(opens in [...]

In the first post of the Greyledge Blog, I introduced the Blog, Greyledge Technologies and my recent shift in employment. I had left off with describing aspects of the service Greyledge provides to physicians who wish to have tighter control over the composition of autologous PRP and BMC preparations for use in a physician’s practice [...]